Volume 2, Number 6, Supplement 4 (November/December 2004) |
| Meeting the Challenges in Cancer Pain Management |
Proceedings from an educational symposium presented at the Oncology Nursing Society’s 29th Annual Congress, April 29, 2004, Anaheim, California |
Jointly sponsored by the Postgraduate Institute for Medicine and Health Management Solutions, Inc. |
|
Information About This Continuing Education Activity
Target Audience • Purpose • Needs Statement • Learning Objectives • Faculty & Disclosure Statements • Media • Method of Participation • Continuing Nursing Education • Disclosure of Unlabeled Use • Disclaimer
| Release date: November 15, 2004 • Expiration date: November 15, 2006 |
|
Contents |
5 |
|
Meeting the Challenges in Cancer Pain Management
Perry G. Fine, MD, Christine Miaskowski, RN, PhD, FAAN, and Judith A. Paice, PhD, RN, FAAN Pain Management Center, University of Utah, Salt Lake City; Department of Physiological Nursing, University of California, San Francisco; and Division of Hematology/Oncology, Cancer Pain Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois
|
22 |
|
CE Post Test, Evaluation Form, and Answer Key
During the period of November 15, 2004, through November 15, 2006, participants must (1) read the learning objectives and faculty disclosures; (2) study the educational activity; (3) complete the post-test by recording the best answer to each question in the answer key on the evaluation form; (4) complete the evaluation form; and (5) mail or fax the evaluation form with answer key to the Postgraduate Institute for Medicine. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post test with a score of 70% or better. Your statement of credit will be mailed to you within 3 weeks. There are no fees for participating and receiving CE credit for this activity.
|
This activity is supported by an educational grant from Endo Pharmaceuticals. |
© 2004 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.
Statements and/or opinions expressed in the reports and communications contained herein are those of the authors and not necessarily those of the editors, editorial staff, publisher, or publishing staff of BioLink Communications, Elsevier Inc., or Endo Pharmaceuticals. The editors, editorial staff, publisher, publishing staff, and End Pharmaceuticals assume no, and disclaim any, responsibility or liability for such material. While every effort has been made to ensure the accuracy of the information presented herein, readers are advised to exercise clinical judgment in assessing the applicability of this information to their own clinical practice and patient population. In addition, readers are cautioned to refer to the manufacturer’s official package labeling before prescribing or administering any drug or diagnostic product mentioned. Neither the editors nor publisher can take responsibility for the statements and opinions expressed by the researchers and clinicians whose work is quoted herein. |
42 kb